Credit Suisse’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $1.17M | Hold |
229,544
| – | – | ﹤0.01% | 2167 |
|
|
2023
Q4 | $1.37M | Sell |
229,544
-1,507
| -0.7% | -$9.03K | ﹤0.01% | 2124 |
|
|
2023
Q3 | $1.64M | Sell |
231,051
-50,966
| -18% | -$361K | ﹤0.01% | 1949 |
|
|
2023
Q2 | $1.99M | Buy |
282,017
+20,984
| +8% | +$148K | ﹤0.01% | 1901 |
|
|
2023
Q1 | $2.18M | Buy |
261,033
+8,782
| +3% | +$73.2K | ﹤0.01% | 1797 |
|
|
2022
Q4 | $2.9M | Buy |
252,251
+2,743
| +1% | +$31.5K | ﹤0.01% | 1649 |
|
|
2022
Q3 | $3.14M | Buy |
249,508
+2,570
| +1% | +$32.4K | ﹤0.01% | 1533 |
|
|
2022
Q2 | $2.61M | Sell |
246,938
-10,851
| -4% | -$115K | ﹤0.01% | 1713 |
|
|
2022
Q1 | $4.19M | Buy |
257,789
+13,881
| +6% | +$226K | ﹤0.01% | 1577 |
|
|
2021
Q4 | $3.38M | Sell |
243,908
-503,137
| -67% | -$6.97M | ﹤0.01% | 1773 |
|
|
2021
Q3 | $10.7M | Buy |
747,045
+31,016
| +4% | +$446K | 0.01% | 1101 |
|
|
2021
Q2 | $11.3M | Buy |
716,029
+479,982
| +203% | +$7.59M | 0.01% | 1084 |
|
|
2021
Q1 | $2.4M | Sell |
236,047
-169,719
| -42% | -$1.73M | ﹤0.01% | 2030 |
|
|
2020
Q4 | $3.02M | Sell |
405,766
-876,380
| -68% | -$6.53M | ﹤0.01% | 1873 |
|
|
2020
Q3 | $4.4M | Buy |
1,282,146
+515,059
| +67% | +$1.77M | ﹤0.01% | 1360 |
|
|
2020
Q2 | $3.66M | Sell |
767,087
-107,304
| -12% | -$511K | ﹤0.01% | 1470 |
|
|
2020
Q1 | $1.75M | Sell |
874,391
-727,924
| -45% | -$1.46M | ﹤0.01% | 1738 |
|
|
2019
Q4 | $5.53M | Buy |
1,602,315
+430,876
| +37% | +$1.49M | ﹤0.01% | 1361 |
|
|
2019
Q3 | $3.36M | Buy |
1,171,439
+1,023,363
| +691% | +$2.93M | ﹤0.01% | 1594 |
|
|
2019
Q2 | $560K | Sell |
148,076
-22,881
| -13% | -$86.5K | ﹤0.01% | 2718 |
|
|
2019
Q1 | $1.39M | Buy |
170,957
+71,362
| +72% | +$581K | ﹤0.01% | 2143 |
|
|
2018
Q4 | $804K | Buy |
99,595
+60,800
| +157% | +$491K | ﹤0.01% | 2457 |
|
|
2018
Q3 | $296K | Sell |
38,795
-23,622
| -38% | -$180K | ﹤0.01% | 3058 |
|
|
2018
Q2 | $358K | Sell |
62,417
-23,597
| -27% | -$135K | ﹤0.01% | 3111 |
|
|
2018
Q1 | $411K | Buy |
86,014
+16,444
| +24% | +$78.6K | ﹤0.01% | 3035 |
|
|
2017
Q4 | $342K | Sell |
69,570
-26,677
| -28% | -$131K | ﹤0.01% | 3090 |
|
|
2017
Q3 | $505K | Sell |
96,247
-10,071
| -9% | -$52.8K | ﹤0.01% | 3046 |
|
|
2017
Q2 | $590K | Sell |
106,318
-4,519
| -4% | -$25.1K | ﹤0.01% | 2667 |
|
|
2017
Q1 | $931K | Buy |
110,837
+46,204
| +71% | +$388K | ﹤0.01% | 2568 |
|
|
2016
Q4 | $409K | Sell |
64,633
-46,772
| -42% | -$296K | ﹤0.01% | 3179 |
|
|
2016
Q3 | $492K | Sell |
111,405
-18,166
| -14% | -$80.2K | ﹤0.01% | 3105 |
|
|
2016
Q2 | $367K | Buy |
129,571
+44,652
| +53% | +$126K | ﹤0.01% | 3291 |
|
|
2016
Q1 | $242K | Buy |
84,919
+27,509
| +48% | +$78.4K | ﹤0.01% | 3306 |
|
|
2015
Q4 | $593K | Sell |
57,410
-6,911
| -11% | -$71.4K | ﹤0.01% | 3024 |
|
|
2015
Q3 | $734K | Sell |
64,321
-118,988
| -65% | -$1.36M | ﹤0.01% | 2915 |
|
|
2015
Q2 | $2.74M | Buy |
183,309
+111,854
| +157% | +$1.67M | ﹤0.01% | 2082 |
|
|
2015
Q1 | $645K | Buy |
71,455
+4,102
| +6% | +$37K | ﹤0.01% | 3099 |
|
|
2014
Q4 | $819K | Sell |
67,353
-819
| -1% | -$9.96K | ﹤0.01% | 2977 |
|
|
2014
Q3 | $666K | Buy |
68,172
+14,684
| +27% | +$143K | ﹤0.01% | 3030 |
|
|
2014
Q2 | $683K | Sell |
53,488
-86,270
| -62% | -$1.1M | ﹤0.01% | 3193 |
|
|
2014
Q1 | $1.48M | Buy |
139,758
+2,475
| +2% | +$26.2K | ﹤0.01% | 2458 |
|
|
2013
Q4 | $1.04M | Buy |
137,283
+123,514
| +897% | +$939K | ﹤0.01% | 2849 |
|
|
2013
Q3 | $100K | Sell |
13,769
-57,956
| -81% | -$421K | ﹤0.01% | 3673 |
|
|
2013
Q2 | $111K | Buy |
+71,725
| New | +$111K | ﹤0.01% | 3597 |
|